share_log

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Director Elsbree David B

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Director Elsbree David B

T2 Biosystems | 4:持股變動聲明-董事 Elsbree David B
美股SEC公告 ·  09/17 17:05

Moomoo AI 已提取核心訊息

David B Elsbree, associated with T2 Biosystems, Inc. [TTOO], completed a sale of 55 shares of common stock on 09/13/2024. The transaction was executed at a price of $2.42 per share, resulting in a total sale value of $133.1. Following the sale, Elsbree's direct holdings in the company decreased to 23 shares. Additionally, there is an indirect holding of 2 shares through Elsbree's spouse.
David B Elsbree, associated with T2 Biosystems, Inc. [TTOO], completed a sale of 55 shares of common stock on 09/13/2024. The transaction was executed at a price of $2.42 per share, resulting in a total sale value of $133.1. Following the sale, Elsbree's direct holdings in the company decreased to 23 shares. Additionally, there is an indirect holding of 2 shares through Elsbree's spouse.
David b Elsbree,與T2 Biosystems,Inc. [TTOO]有關,於09/13/2024完成了對55股普通股的出售。交易價格爲每股$2.42,總銷售價值爲$133.1。此次銷售後,Elsbree在該公司的直接持股減少至23股。此外,Elsbree的配偶通過間接持有2股。
David b Elsbree,與T2 Biosystems,Inc. [TTOO]有關,於09/13/2024完成了對55股普通股的出售。交易價格爲每股$2.42,總銷售價值爲$133.1。此次銷售後,Elsbree在該公司的直接持股減少至23股。此外,Elsbree的配偶通過間接持有2股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息